An unblinded, randomised phase II study of platinum-based chemotherapy with vitamin B12and folic acid supplementation in the treatment of lung cancer with plasma homocysteine blood levels as a biomarker of severe neutropenic toxicity-Reference-Cited by-同舟云学术

An unblinded, randomised phase II study of platinum-based chemotherapy with vitamin B12and folic acid supplementation in the treatment of lung cancer with plasma homocysteine blood levels as a biomarker of severe neutropenic toxicity

Published:2014-12 Issue:1 Volume:1 Page:e000061
ISSN:2052-4439
Container-title:BMJ Open Respiratory Research
language:en
Short-container-title:BMJ Open Resp Res

Author:

Minchom A R,Saksornchai K,Bhosle J,Gunapala R,Puglisi M,Lu S K,Nimako K,Coward J,Yu K C,Bordi P,Popat S,O'Brien M E R

Publisher

BMJ

Subject

Pulmonary and Respiratory Medicine

Reference14 articles.

1. NICE guidance for screening for malnutrition: implications for lung cancer services;Chauhan;Thorax,2006

2. Cisplatin versus carboplatin in combination for advanced non-small cell lung cancer (review);de Castria;Cochrane Database Syst Rev,2013

3. Cetuximab plus chemotherapy in patients with advanced non small cell lung cancer (FLEX): an open-label randomised, phase III trial;Pirker;Lancet,2009

4. Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma;Vogelzang;J Clin Oncol,2003

5. Randomised phase II study of amrubicin as single agent or in combination with cisplatin versus cisplatin etoposide as first-line treatment in patients with extensive stage small cell lung cancer—EORTC 08062;O'Brien;Eur J Cancer.,2011

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effects of nutritional interventions on cognitive function in adult cancer survivors: A systematic review;Journal of Clinical Nursing;2024-07-17

2. Hematological Toxicity in Lung Cancer;Medical Radiology;2022

3. A prospective observational study of on-treatment plasma homocysteine levels as a biomarker of toxicity, depression and vitamin supplementation lead-in time pre pemetrexed, in patients with non-small cell lung cancer and malignant mesothelioma;PLOS ONE;2019-11-25